Sortina Pharma completes seed-financing to develop breakthrough cancer treatments

Sortina Pharma AB today announces a financing led by Eir Ventures and GU Ventures to unlock the potential of proprietary anti-sortilin cancer therapy to cure aggressive cancer.
Läs mer